Este artículo tiene más de 1 año de antigüedad

Future and innovative approaches to the management of chronic heart failure

| CardioTV

Prof. Bernard Gersh analyses the current situation of clinical trials and beneficts within the XVIII International Symposium on Ischemic Heart Disease.

  • Nowadays there is an overwhelming number of clinical trials available to physicians, however its impact on clinical practice seems quite limited. What are your thoughts on this?
  • We have seen many very promising drugs, with a solid investigational backgroud, failing to demonstrate a clinical benefit in randomized clinical trials. What is the reason? Are we asking these drugs too much?